Obsidian Therapeutics is developing a new class of regulated cell and gene therapeutics
Obsidian Therapeutics, founded by Atlas Venture in 2016, is developing next-generation cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. We are based in Cambridge, MA and are actively seeking talented scientists to work in a fast-paced, innovative environment.
Obsidian Therapeutics, Inc.
130 Brookline Street, Suite 201
Cambridge MA 02139